ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |
rdf:type |
node1 |
ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |
rdf:type |
owl:Thing |
ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |
rdf:type |
prov:Person |
ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |
rdf:type |
foaf:Person |
ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |
owl:sameAs |
https://semopenalex.org/author/A5000981515 |
ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |
foaf:familyName |
Iida |
ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |
foaf:givenName |
Satofumi |
ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |
foaf:name |
Satofumi Iida |
ripekg:work/10.1007%2Fs13318-014-0242-5The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties |
dcterms:creator |
ripekg:author/RIPEAUD1D93350CB44FD5CSatofumi Iida |